Login / Signup

Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group.

Anne Mea SpanjaartQamar-Un-Nisa ChaudhryRafael De la Cámara LLanzáGloria TridelloValentín Ortiz-MaldonadoAlvaro Urbano-IspizuaPere BarbaMi KwonDolores CaballeroPierre SesquesEmmanuel BachyRoberta Di BlasiCatherine ThieblemontFriso G J CalkoenPim G N J MutsaersJohan A MaertensLivia GiannoniEmma NicholsonMatthew CollinCarlos Pinho VazElisabetta MetafuniJoaquin Martinez-LopezFiona L DignanJosep-Maria RiberaArnon NaglerFrantisek FolberRobin SandersonAdrian J C BloorFabio CiceriNina KnelangeFrancis AyukNicolaus KrogerMarie José KerstenStephan Mielke
Published in: Leukemia (2021)
Keyphrases
  • cell therapy
  • infectious diseases
  • stem cells
  • mesenchymal stem cells
  • diffuse large b cell lymphoma
  • bone marrow